(-)-Hinokinin-loaded poly(d,l-lactide-co-glycolide) microparticles for Chagas disease

Parasitology Research

Volumn 106, Issue 3, 2010, Pages 703-708

  Saraiva, Juliana ^a   Lira, Ana Amélia Moreira ^a   Esperandim, Viviane Rodrigues ^a   Da Silva Ferreira, Daniele ^a   Ferraudo, Antônio Sérgio ^b   Bastos, Jairo Kenupp ^a   E Silva, Márcio Luís Andrade ^c   De Gaitani, Cristiane Masetto ^a   De Albuquerque, Sérgio ^a   Marchetti, Juliana Maldonado ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c UNIVERSIDADE DE FRANCA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITRYPANOSOMAL AGENT; HINOKININ; POLYGLACTIN; SOLVENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL ACTIVITY; CHAGAS DISEASE; CONTROLLED STUDY; EMULSION; ENCAPSULATION; EVAPORATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; KINETICS; MORPHOLOGICAL TRAIT; MOUSE; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; PRODUCTIVITY; SURFACE PROPERTY; SUSTAINED DRUG RELEASE;

4-BUTYROLACTONE; ANIMALS; ANTIPROTOZOAL AGENTS; CHAGAS DISEASE; DELAYED-ACTION PREPARATIONS; DIOXANES; DIOXOLES; DISEASE MODELS, ANIMAL; HUMANS; LACTIC ACID; LIGNANS; MICE; MICROSPHERES; PARASITEMIA; POLYGLYCOLIC ACID; TREATMENT OUTCOME; TRYPANOSOMA CRUZI;

MUS; TRYPANOSOMA CRUZI;

EID: 77949264976     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-010-1725-1     Document Type: Article

References (33)

1. SD Allison 2008 Analysis of initial burst in PLGA microparticles Expert Opin Drug Deliv 5 6 615 628 10.1517/17425247.5.6.615 1:CAS:528: DC%2BD1cXmslOrtLc%3D 18532918 (Pubitemid 351998252)
2. JK Bastos OR Gottlieb JS Sarti DS Filho 1996 Isolation of lignans and sesquiterpenoids from leaves of Zanthoxylum naranjillo Nat Prod Lett 9 65 70 1:CAS:528:DyaK28XnsFektrY%3D
3. JK Bastos S Albuquerque MLA Silva 1999 Evaluation of the trypanocidal activity of lignans isolated from the leaves of Zanthoxylum naranjillo Planta Med 65 541 544 10.1055/s-1999-14012 1:CAS:528:DyaK1MXlsFSntr4%3D 10483375 (Pubitemid 29399957)
4. JK Bastos JCT Carvalho GHB Souza AHP Pedrazzi SJ Sarti 2001 Anti-inflammatory activity of hinokinin, a lignan from the leaves of Zanthoxyllum naranjillo Griseb J. Ethnopharmacol 75 279 282 10.1016/S0378- 8741(01)00171-4 1:CAS:528:DC%2BD3MXisF2ku7c%3D 11297863 (Pubitemid 32297745)
5. DT Birnbaum JD Kosmala DB Henthorn Brannon-Peppas 2000 Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release J Control Release 65 3 375 387 10.1016/S0168-3659(99)00219-9 1:CAS:528:DC%2BD3cXhtl2qsbw%3D 10699296 (Pubitemid 30122940)
6. Z Brener 1962 Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi Rev Inst Med Trop São Paulo 4 389 396 1:STN:280:DyaF383gslWktw%3D%3D 14015230
7. R Causon 1997 Validation of chromatographic methods in biomedical analysis view point and discussion J Chromatogr B 689 175 180 10.1016/S0378-4347(96)00297-6 1:CAS:528:DyaK2sXns1Sqsw%3D%3D (Pubitemid 27089650)
8. M Cegnar J Kristl J Kos 2005 Nanoscale polymer carriers to deliver chemotherapeutic agents tumours Expert Opinion on Biological Therapy 5 12 1557 1569 10.1517/14712598.5.12.1557 1:CAS:528:DC%2BD2MXht1Gks7rI 16318420 (Pubitemid 41771847)
9. JL Charlton 1998 Antiviral activity of lignans J Nat Prod 61 1447 1451 10.1021/np980136z 1:CAS:528:DyaK1cXntFegsbg%3D 9834179 (Pubitemid 28555125)
10. AM Clark 1996 Natural products as a resource for new drugs Pharmaceutical Res 13 1133 1141 10.1023/A:1016091631721 1:CAS:528:DyaK28XltFWqtrk%3D (Pubitemid 26279315)
11. SL Croft 1997 The current status of antiparasite chemotherapy Parasitology 114 3 15
12. R da Silva GH de Souza AA da Silva VA de Souza AC Pereira VA Royo ML Silva PM Donate AL de Matos Araújo JC Carvalho JK Bastos 2005 Synthesis and biological activity evaluation of lignan lactones derived from (-)-cubebin Bioorg Med Chem Lett 15 4 1033 1037 10.1016/j.bmcl.2004.12.035 15686907 (Pubitemid 40458644)
13. SL de Castro 1993 The challenge of Chagas disease chemotherapy: an update of drugs assayed against Trypanosoma cruzi Acta Trop 53 2 83 98 10.1016/0001-706X(93)90021-3 8098901
14. VA de Souza R da Silva AC Pereira VA Royo J Saraiva M Montanheiro GH de Souza AA da Silva Filho MD Grando PM Donate JK Bastos S Albuquerque ML Silva 2005 Trypanocidal activity of (-)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi Bioorg Med Chem Lett 15 303 307 10.1016/j.bmcl.2004. 10.079 15603944 (Pubitemid 39647140)
15. R Docampo 2001 Recent developments in the chemotherapy of Chagas disease Curr Pharm Des 7 12 1157 1164 10.2174/1381612013397546 1:CAS:528: DC%2BD3MXlt1Ggur8%3D 11472259 (Pubitemid 32640575)
16. ML Hans AM Lowman 2002 Biodegradable nanoparticles for drug delivery and targeting Curr Opin Sol State Mater Sci 6 319 327 10.1016/S1359-0286(02)00117-1 1:CAS:528:DC%2BD38XpsFegtLg%3D (Pubitemid 36238389)
17. VC Heleno R da Silva S Pedersoli S de Albuquerque JK Bastos ML Silva PM Donate GV da Silva JL Lopes 2006 Detailed 1H and 13C NMR structural assignment of three biologically active lignan lactones Spectrochim Acta A Mol Biomol Spectrosc 63 1 234 239 10.1016/j.saa.2005.04.047 16344252
18. J Herrmann R Bodmeier 1998 Biodegradable, somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods Eur J Pharm Biopharm 45 1 75 82 10.1016/S0939-6411(97)00125-2 1:CAS:528:DyaK1cXhtlKjt7k%3D 9689538 (Pubitemid 28248258)
19. T Higuchi 1961 Rate of release of medicaments from ointment bases containing drugs in suspension J Pharm Sci 50 874 875 10.1002/jps.2600501018 1:CAS:528:DyaF38Xhtlahsg%3D%3D 13907269
20. T Higuchi 1963 Mechanism of sustained-action medication. theoretical analysis of rate of release of solid drugs dispersed in solid matrices J Pharm Sci 52 1145 1149 10.1002/jps.2600521210 1:CAS:528:DyaF2cXlt1Whsg%3D%3D 14088963
21. RA Jain 2000 The manufacturing techniques of various drug-loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices Biomaterials 21 23 2475 2490 10.1016/S0142-9612(00)00115-0 1:CAS:528:DC%2BD3cXmslKmtL0%3D 11055295
22. AA Lira FC Rossetti DM Nanclares AF Neto MV Bentley JM Marchetti 2008 Preparation and characterization of chitosan-treated alginate microparticles incorporating all-trans retinoic acid J Microencapsul 30 1 8
23. CA Montanari VS Bolzani 2001 Planejamento racional de fármacos baseado em produtos naturais Química Nova 24 105 111 10.1590/S0100- 40422001000100018 1:CAS:528:DC%2BD3MXmsFSqsrg%3D
24. T Niwa H Takeuchi T Hino N Kunou Y Kawashima 1994 In vitro drug release behavior of d,l-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method J Pharm Sci 83 5 727 732 10.1002/jps.2600830527 1:CAS:528:DyaK2cXisl2qur0%3D 8071830 (Pubitemid 24219829)
25. M Paulino F Iribarne M Dubin S Aguilera-Morales O Tapia AO Stoppani 2005 The chemotherapy of Chagas disease: an overview Mini Rev Med Chem 5 5 499 519 10.2174/1389557053765565 1:CAS:528:DC%2BD2MXjslWqs7Y%3D 15892691 (Pubitemid 40601640)
26. AL Piccinelli N Mahmood G Mora L Poveda F De Simone L Rastrelli 2005 Anti-HIV activity of dibenzylbutyrolactone-type lignans from phenax species endemic in Costa Rica J Pharm Pharmacol 57 1109 1115 10.1211/jpp.57.9.0006 1:CAS:528:DC%2BD2MXhtVKntrzE 16105232 (Pubitemid 41391770)
27. MN Ravi Kumar 2000 Nano- and microparticles as controlled drug-delivery devices J Pharm Pharm Sci 3 2 234 58 1:STN:280:DC%2BD3cvks1Wqtw%3D%3D 10994037
28. J Rodriques Coura SL de Castro 2002 A critical review on Chagas disease chemotherapy Mem Inst Oswaldo Cruz 97 1 3 24 11992141
29. J Saraiva C Vega M Rolon R da Silva ML Silva PM Donate JK Bastos A Gomez-Barrio S de Albuquerque 2007 In vitro and in vivo activity of lignan lactones derivatives against Trypanosoma cruzi Parasitol Res 100 4 791 795 10.1007/s00436-006-0327-4 17053932 (Pubitemid 46175245)
30. GH Souza AA da Silva Filho VA de Souza AC Pereira VA Royo ML Silva R da Silva PM Donate JC Carvalho JK Bastos 2004 Analgesic and anti-inflammatory activities evaluation of (-)-O-acetyl, (-)-O-methyl, (-)-O-dimethylethylamine (-)-hinokinin and their preparation from (-)-hinokinin Fármaco 59 55 59 10.1016/j.farmac.2003.07.012 1:CAS:528:DC%2BD2cXnvVylsA%3D%3D 14751317 (Pubitemid 38134285)
31. H Ueda Y Tabata 2003 Polyhydroxyalkanonate derivatives in current clinical applications and trials Adv Drug Deliv Rev 55 4 501 518 10.1016/S0169-409X(03)00037-1 1:CAS:528:DC%2BD3sXivV2qs7Y%3D 12706048 (Pubitemid 36426927)
32. JA Urbina R Docampo 2003 Specific chemotherapy of Chagas disease: controversies and advances Trends Parasitol 19 11 495 501 10.1016/j.pt.2003.09. 001 1:CAS:528:DC%2BD3sXosVyisLw%3D 14580960 (Pubitemid 37329658)
33. World Health Organization (2007) Reporte del grupo de trabajo científico sobre la enfermedad de Chagas. Document TDR/SWG/09. http://apps.who.int/tdr/svc/publications/tdr-research-publications/ reporte-enfermedad-chagas. Accessed 8 Oct 2009